Technology area: Biotechnology & Pharmaceuticals
17 pending office actions • 11 art units • 14 examiners • 0 of 17 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Zoetis LLC is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 action is assigned to 1 distinct examiner and 1 distinct art unit. The portfolio's current activity is focused on this 1 pending matter. Practitioners should note that the 1 distinct art unit involved indicates a specialized focus within the biotechnology field. The concentration of the portfolio means that the company's immediate patent strategy is concentrated on 1 point of contact within the patent office. This allows for a targeted approach to prosecution.
The busiest examiner is HASTINGS, ALISON AZAR, who is responsible for 1 pending office action. Because there is 1 pending office action in total, this 1 examiner is the only one currently reviewing applications for the company. The results of this 1 prosecution will determine the company's immediate success in this technology area. This centralization means that the company's immediate patent prospects are entirely subject to the review and requirements of this 1 individual. Building a clear and persuasive record with HASTINGS, ALISON AZAR is the primary task for the company's current prosecution efforts. Practitioners can focus exclusively on the preferences of this 1 examiner to advance the 1 pending application.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (18%) |
| §103 only | 1 (6%) |
| §112 only | 3 (18%) |
| Double-patenting only | 1 (6%) |
| Double-patenting + other | 4 (24%) |
| Multi-statute (no §101) | 5 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAOUD, CHRISTINE J | 2 | 57.9% | +37.5% |
| SITTON, JEHANNE SOUAYA | 2 | 53.2% | +47.5% |
| GIERE, REBECCA M | 2 | 73.7% | +32.3% |
| GRASER, JENNIFER E | 1 | 76.8% | +23.2% |
| NOBLE, MARCIA STEPHENS | 1 | 67.2% | +39.5% |
| CORNELIUS, CLAIRE ADRIENNE | 1 | 71.4% | +0.0% |
| CHESTNUT, BARRY A | 1 | 73.9% | +6.3% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
| DABKOWSKI, ERINNE R | 1 | 55.8% | +68.7% |
| SIMMONS, CHRIS E | 1 | 34.2% | +19.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17806238 | METHODS AND COMPOSITIONS FOR CANCER DETECTION, CHARACTERIZATION OR MANAGEMENT IN COMPANION ANIMALS | VANN-OJUEKAIYE, KENDRA RAYCHELL | 99d overdue |
| 18266053 | MUTATIONS IN FELINE ANTIBODY CONSTANT REGIONS | CUNNINGCHEN, KATHLEEN MARY | 29d |
| 19570699 | CANINE ANTIBODY VARIANTS | SAOUD, CHRISTINE J | — |
| 18884796 | ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM | NOBLE, MARCIA STEPHENS | — |
| 18721713 | COMPOSITIONS AND METHODS FOR EXPRESSING ANTIGENS ON CELL MEMBRANE | CORNELIUS, CLAIRE ADRIENNE | — |
| 18655845 | METHODS FOR DETECTING CANCER USING CIRCULATING CELL-FREE DNA | SITTON, JEHANNE SOUAYA | — |
| 18557791 | RAPID MILK SAMPLE PREPARATION METHOD COMPATIBLE WITH MOLECULAR TESTS | SITTON, JEHANNE SOUAYA | — |
| 18037514 | BOVINE ANTIBODY VARIANTS | JUEDES, AMY E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18331697 | NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO | GIERE, REBECCA M | 45d overdue |
| 18174251 | SIGNAL AMPLIFICATION IN SOLUTION-BASED PLASMONIC SPECIFIC-BINDING PARTNER ASSAYS | GIERE, REBECCA M | 23d overdue |
| 19570699 | CANINE ANTIBODY VARIANTS | SAOUD, CHRISTINE J | — |
| 18864723 | VACCINES AGAINST MORITELLA VISCOSA | GRASER, JENNIFER E | — |
| 18884796 | ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM | NOBLE, MARCIA STEPHENS | — |
| 18719464 | COMPOSITIONS AND METHODS FOR ACTIVATING INNATE IMMUNITY | KATAKAM, SUDHAKAR | — |
| 18655845 | METHODS FOR DETECTING CANCER USING CIRCULATING CELL-FREE DNA | SITTON, JEHANNE SOUAYA | — |
| 18294706 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | DABKOWSKI, ERINNE R | — |
| Art Unit | Apps |
|---|---|
| 1645 | 3 |
| 1682 | 3 |
| 1672 | 2 |
| 1677 | 2 |
| 1632 | 1 |
| 1658 | 1 |
| 1654 | 1 |
| 1622 | 1 |
| 1646 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19570699 | CANINE ANTIBODY VARIANTS | SAOUD, CHRISTINE J | 1645 | §103§112 | Non-Final OA | — | Pending | Mar 18, 2026 |
| 18864723 | VACCINES AGAINST MORITELLA VISCOSA | GRASER, JENNIFER E | 1645 | §112 | Non-Final OA | — | Pending | Nov 11, 2024 |
| 18884796 | ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM | NOBLE, MARCIA STEPHENS | 1632 | §103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18721713 | COMPOSITIONS AND METHODS FOR EXPRESSING ANTIGENS ON CELL MEMBRANE | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§103§112DP | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18721719 | COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS | CHESTNUT, BARRY A | 1672 | §112 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18719464 | COMPOSITIONS AND METHODS FOR ACTIVATING INNATE IMMUNITY | KATAKAM, SUDHAKAR | 1658 | §103DP | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18655845 | METHODS FOR DETECTING CANCER USING CIRCULATING CELL-FREE DNA | SITTON, JEHANNE SOUAYA | 1682 | §101§102§103 | Non-Final OA | — | Pending | May 06, 2024 |
| 18294706 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | DABKOWSKI, ERINNE R | 1654 | §103§112DP | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18557791 | RAPID MILK SAMPLE PREPARATION METHOD COMPATIBLE WITH MOLECULAR TESTS | SITTON, JEHANNE SOUAYA | 1682 | §102§103§112 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18462535 | LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS | SIMMONS, CHRIS E | 1622 | §103§112DP | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18266053 | MUTATIONS IN FELINE ANTIBODY CONSTANT REGIONS | CUNNINGCHEN, KATHLEEN MARY | 1646 | §102§103§112Other | Final Rejection | 29d | Pending | Jun 08, 2023 |
| 18331697 | NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO | GIERE, REBECCA M | 1677 | DP | Final Rejection | 45d overdue | Pending | Jun 08, 2023 |
| 18037514 | BOVINE ANTIBODY VARIANTS | JUEDES, AMY E | 1644 | §101§102§112 | Non-Final OA | — | Pending | May 17, 2023 |
| 18174251 | SIGNAL AMPLIFICATION IN SOLUTION-BASED PLASMONIC SPECIFIC-BINDING PARTNER ASSAYS | GIERE, REBECCA M | 1677 | §103DP | Non-Final OA | 23d overdue | Pending | Feb 24, 2023 |
| 18011282 | FELINE ANTIBODY VARIANTS FOR IMPROVING STABILITY | DAHLE, CHUN WU | 1641 | §112 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 17918853 | CANINE ANTIBODY VARIANTS | SAOUD, CHRISTINE J | 1645 | §103Other | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17806238 | METHODS AND COMPOSITIONS FOR CANCER DETECTION, CHARACTERIZATION OR MANAGEMENT IN COMPANION ANIMALS | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103§112 | Final Rejection | 99d overdue | Pending | Jun 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZoetis LLC has 17 pending office actions as of October 2026, spread across 11 art units and 14 examiners.
Christine J Saoud has the most, with 2 of Zoetis LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
